Current Pharmaceutical Design
Title: Preface
Volume: 9 Issue: 7
Author(s): Maurizio Botta
Affiliation:
Export Options
About this article
Cite this article as:
Botta Maurizio, Preface, Current Pharmaceutical Design 2003; 9 (7) . https://dx.doi.org/10.2174/1381612033391522
DOI https://dx.doi.org/10.2174/1381612033391522 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
11
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Immunotherapeutic Approaches in MS: Update on Pathophysiology and Emerging Agents or Strategies 2006
Endocrine, Metabolic & Immune Disorders - Drug Targets Arachidonic Acid Signaling in Pathogenesis of Allergy: Therapeutic Implications
Current Drug Targets - Inflammation & Allergy Evolution of Reactive mPEG Polymers for the Conjugation of Peptides and Proteins
Current Organic Chemistry Epidemiology and Management of Acute Kidney Injury in Hepatocellular Carcinoma Patients Undergoing Transcatheter Arterial Chemoembolization
Current Protein & Peptide Science New Insights in the Mechanism of Bone Loss in Arthritis
Current Pharmaceutical Design Editorial (Thematic Issue: Cell Therapy and Regenerative Medicine)
Current Molecular Pharmacology Distinctive Features in Spondyloarthritis Between Women and Man in Moroccan Context: Disease Beginning, Clinical Manifestations, Disease Activity and Function Scores
Current Rheumatology Reviews Oral Immune Regulation: A New Mode of Therapy Against Chronic Viral Infections
Recent Patents on Anti-Infective Drug Discovery Matrix Metalloproteinase-2 and Epidermal Growth Factor are Decreased in Platelets of Alzheimer Patients
Current Alzheimer Research Cell Penetrating Peptides for Tumor Targeting
Current Pharmaceutical Biotechnology Incomplete Invention of Drugs
Recent Patents on Inflammation & Allergy Drug Discovery Serotonin Control of Dopaminergic Neurotransmission: Focus on 5-HT2 Receptors
Current Neuropharmacology Nanoparticles: A Neurotoxicological Perspective
CNS & Neurological Disorders - Drug Targets The Role of Bevacizumab in Advanced Epithelial Ovarian Cancer
Current Pharmaceutical Design Analysis of Nonsteroidal Anti-inflammatory Drugs by using Microfluidic Techniques: A Review
Current Pharmaceutical Analysis Early Brain Injury or Vasospasm? An Overview of Common Mechanisms
Current Drug Targets Immigration, Social Environment and Onset of Psychotic Disorders
Current Pharmaceutical Design Ursolic Acid and Oleanolic Acid: Pentacyclic Terpenoids with Promising Anti-Inflammatory Activities
Recent Patents on Inflammation & Allergy Drug Discovery Pathophysiology of Acute and Infected Pancreatitis
Infectious Disorders - Drug Targets Lipoxygenase (LOX) Pathway: A Promising Target to Combat Cancer
Current Pharmaceutical Design